Insight before capital. An engineer's lens on autoimmune and inflammatory therapeutics.
More than eighty autoimmune diseases are studied, funded, and treated as separate problems — while the underlying biology is deeply connected. The result is slower diagnosis, fragmented research, and billions spent without connecting shared mechanisms.
ASDF pairs an engineer's pattern-recognition approach with regulatory expertise from a former FDA Division Director to identify companies working across these shared failure modes. We build relationships and domain expertise before we write checks.
Software engineer. Tesla, SpaceX, Nike. Finds and fixes bugs in complex systems for a living — applies the same lens to the immune system. Lives with Type 1 diabetes.
Former FDA Division Director, inflammation and immunology therapeutics. Former Harvard Medical School faculty. Three decades of regulatory expertise and clinical networks.
Periodic updates on our programs and the autoimmune landscape.
tyler.l@asdfglobal.com